NASDAQ:CGNX - Cognex Stock Price, Price Target & More

Cognex trades on the NASDAQ under the ticker symbol "CGNX."

Cognex declared a quarterly dividend on Monday, April 30th. Investors of record on Friday, May 18th will be paid a dividend of $0.045 per share on Friday, June 1st. This represents a $0.18 dividend on an annualized basis and a yield of 0.40%. The ex-dividend date of this dividend is Thursday, May 17th. View Cognex's Dividend History.

Shares of Cognex split before market open on Monday, December 4th 2017. The 2-1 split was announced on Monday, October 30th 2017. The newly minted shares were payable to shareholders after the market closes on Friday, December 1st 2017. An investor that had 100 shares of Cognex stock prior to the split would have 200 shares after the split.

Cognex announced that its board has authorized a share repurchase plan on Friday, February 16th 2018, which authorizes the company to repurchase $150,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization authorizes the company to reacquire shares of its stock through open market purchases. Stock repurchase plans are typically an indication that the company's management believes its stock is undervalued.

Cognex Co. (NASDAQ:CGNX) announced its earnings results on Thursday, February, 15th. The scientific and technical instruments company reported $0.30 EPS for the quarter, topping the Zacks' consensus estimate of $0.25 by $0.05. The scientific and technical instruments company had revenue of $180.37 million for the quarter, compared to analysts' expectations of $178.75 million. Cognex had a net margin of 21.56% and a return on equity of 23.08%. The business's revenue for the quarter was up 39.5% compared to the same quarter last year. During the same period in the prior year, the business posted $0.20 EPS. View Cognex's Earnings History.

Cognex is scheduled to release their next quarterly earnings announcement on Monday, July, 30th 2018. View Earnings Estimates for Cognex.

9 brokers have issued 12 month price objectives for Cognex's shares. Their forecasts range from $40.00 to $80.00. On average, they expect Cognex's stock price to reach $57.4167 in the next twelve months. This suggests a possible upside of 26.1% from the stock's current price. View Analyst Ratings for Cognex.

9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cognex in the last year. There are currently 1 sell rating, 3 hold ratings and 5 buy ratings for the stock, resulting in a consensus recommendation of "Hold."

Some companies that are related to Cognex include Roper Technologies (ROP), Fortive (FTV), Keysight Technologies (KEYS), Sensata Technologies (ST), MKS Instruments (MKSI), Orbotech (ORBK), Esterline Technologies (ESL), Rudolph Technologies (RTEC), Mesa Laboratories (MLAB), Hurco Companies (HURC), Universal Detection Technology (UNDT), Clearsign Combustion (CLIR), Sypris Solutions (SYPR), Elbit Vision Systems (EVSNF) and Hickok (HICKA).

News headlines about CGNX stock have been trending somewhat positive recently, according to Accern. Accern identifies negative and positive news coverage by reviewing more than twenty million news and blog sources in real time. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Cognex earned a news impact score of 0.08 on Accern's scale. They also assigned media coverage about the scientific and technical instruments company an impact score of 45.30 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the company's share price in the next several days.

Cognex's stock is owned by a variety of of retail and institutional investors. Top institutional investors include American Capital Management Inc. (0.93%), Handelsbanken Fonder AB (0.32%), Welch & Forbes LLC (0.24%), Riverbridge Partners LLC (0.21%), Bellecapital International Ltd. (0.04%) and DnB Asset Management AS (0.04%). Company insiders that own Cognex stock include Anthony Sun, Bruce Robinson J, Jeffrey Benjamin Miller, Jerry A Schneider, John J Curran, Patrick Alias, Richard Morin, Robert Willett and Theodor Krantz. View Institutional Ownership Trends for Cognex.

CGNX stock was sold by a variety of institutional investors in the last quarter, including NN Investment Partners Holdings N.V., Essex Investment Management Co. LLC and Riverbridge Partners LLC. Company insiders that have sold Cognex company stock in the last year include Anthony Sun, Bruce Robinson J, Jeffrey Benjamin Miller, Jerry A Schneider, John J Curran, Patrick Alias, Robert Willett and Theodor Krantz. View Insider Buying and Selling for Cognex.

CGNX stock was acquired by a variety of institutional investors in the last quarter, including Welch & Forbes LLC, Bellecapital International Ltd., DnB Asset Management AS, Pennsylvania Trust Co, Bank of Montreal Can, Denali Advisors LLC, Handelsbanken Fonder AB and First Citizens Bank & Trust Co.. View Insider Buying and Selling for Cognex.

Shares of CGNX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of CGNX stock can currently be purchased for approximately $45.54.

Cognex has a market capitalization of $7.91 billion and generates $747.95 million in revenue each year. The scientific and technical instruments company earns $177.17 million in net income (profit) each year or $1.45 on an earnings per share basis. Cognex employs 1,771 workers across the globe.

Cognex's mailing address is ONE VISION DRIVE, NATICK MA, 01760. The scientific and technical instruments company can be reached via phone at 508-650-3000 or via email at [email protected]